Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MALIN: Intrastromal Voriconazole for Fungal Corneal Ulcers
NCT02731638Phase 3Completed
- Sponsor
- University of California, San Francisco
- Start
- Sep 2016
- Primary completion
- Jul 2018
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
Phase 3, randomised, single-blind trial of voriconazole in fungal keratitis (FK) (2 arms), sponsored by University of California, San Francisco. Primary endpoint: Culture Positivity Using Potassium Hydroxide (KOH) Wet Mount at 3 days. Started Sep 2016; status: completed.
02
Drugs
voriconazole
03
Conditions
fungal keratitis (FK)
Beyond the preview
Go deeper on NCT02731638.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02731638.